Sign In
Buy SNGX
$0.362
-0.0003 (-0.0829%)
At Close: Jul 28, 2026
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study PRINCETON, N.J. , April 3, 2024 /PRNewswire/ -- Sol
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
07:30am, Friday, 15'th Mar 2024
PRINCETON, N.J. , March 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix Announces Formation of Behçet's Disease Medical Advisory Board
07:30am, Thursday, 08'th Feb 2024
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J. , Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biophar
Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
09:00am, Friday, 26'th Jan 2024
ORLANDO, FL / ACCESSWIRE / January 26, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Mobilicom Limited (NASDAQ:MOB) on the RedChip Small Stocks, Big Money™ show
Soligenix to Present at The Microcap Conference
07:30am, Thursday, 25'th Jan 2024
PRINCETON, N.J. , Jan. 25, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease
07:30am, Monday, 08'th Jan 2024
PRINCETON, N.J. , Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
07:30am, Thursday, 04'th Jan 2024
Clinical Success Achieved in Second Cohort of Patients PRINCETON, N.J. , Jan. 4, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company
Soligenix shares rocket as bivalent vaccine shows preclinical efficacy
09:19am, Tuesday, 02'nd Jan 2024
Soligenix (NASDAQ:SNGX) shares added almost 35% before the opening bell on Tuesday after it revealed its novel vaccine provided 100% protection against two deadly infections in non-human primate model
Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J. , Jan. 2, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix o
Why Is Soligenix (SNGX) Stock Up 285% Today?
11:07am, Thursday, 30'th Nov 2023
Soligenix (NASDAQ: SNGX ) stock is on the rise Thursday after the company got approval from the Food and Drug Administration for a Phase 2a clinical trial of SGX945. According to a press release from
Soligenix shares spike after T-cell lymphoma candidate HyBryte aces compatibility study results
11:14am, Thursday, 04'th May 2023
Soligenix (NASDAQ:SNGX) shares more than doubled on Thursday after the biopharmaceutical company announced positive results from a compatibility study of its investigational therapeutic HyBryte in cut
Nasdaq Turns Higher; Soligenix Shares Plunge
07:38pm, Tuesday, 14'th Feb 2023 Benzinga
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday.
The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
07:26pm, Tuesday, 14'th Feb 2023 Benzinga
Gainers
Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Boxlight Corporation (NASDAQ: BOXL
Crude Oil Down 1%; SkyWater Technology Shares Spike Higher
05:48pm, Tuesday, 14'th Feb 2023 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday.
The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P 5
Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January
02:58pm, Tuesday, 14'th Feb 2023 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42
